Company Description
Everspin Technologies, Inc. manufactures and sells magnetoresistive random access memory (MRAM) technologies in the United States, Japan, Hong Kong, Germany, Singapore, Canada, and internationally.
It offers Toggle MRAM, spin-transfer torque MRAM, and tunnel magneto resistance sensor products, as well as foundry services for MRAM products and magnetic tunnel junction (MTJ)-based sensors.
The company provides its products for applications, including industrial, medical, automotive/transportation, aerospace, and data center markets.
It serves original equipment manufacturers, contract manufacturers, and original design manufacturers through a direct sales channel, and a network of representatives and distributors.
Everspin Technologies, Inc. was incorporated in 2008 and is headquartered in Chandler, Arizona.
| Country | United States |
| Founded | 2008 |
| IPO Date | Oct 7, 2016 |
| Industry | Semiconductors |
| Sector | Technology |
| Employees | 85 |
| CEO | Sanjeev Aggarwal |
Contact Details
Address: 5670 West Chandler Boulevard, Suite 130 Chandler, Arizona 85226 United States | |
| Phone | 480 347 1111 |
| Website | everspin.com |
Stock Details
| Ticker Symbol | MRAM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001438423 |
| CUSIP Number | 30041T104 |
| ISIN Number | US30041T1043 |
| Employer ID | 26-2640654 |
| SIC Code | 3674 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sanjeev Aggarwal Ph.D. | President, Chief Executive Officer and Director |
| William Cooper | Chief Financial Officer |
| Sean Dougherty | Vice President of Sales |
| Amit Shah | Vice President of Operations |
| Kerry Nagel | Vice President of Technology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2026 | 8-K | Current Report |
| Apr 7, 2026 | ARS | Filing |
| Apr 7, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 7, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 5, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 4, 2026 | 10-K | Annual Report |
| Mar 4, 2026 | 8-K | Current Report |
| Feb 2, 2026 | 8-K | Current Report |
| Nov 25, 2025 | 144 | Filing |
| Nov 12, 2025 | SCHEDULE 13G/A | Filing |